HMGB1 and Myocardial fibrosis: The present study shows that treatment with resveratrol can prevent HMGB1/RAGE/TLR4/NF-κB pathway, oxidative damage, myocardial fibrosis, and inflammation in STZ-induced type 1 diabetic hearts.